Pieris Pharmaceuticals Inc (PIRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PIRS | BMY | AMGN | GILD | REGN |
| Company | Pieris Pharmaceuticals Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 11.50 | 44.68 | 265.72 | 65.50 | 881.72 |
| High | 11.93 | 45.37 | 271.68 | 66.35 | 887.48 |
| Low | 11.50 | 44.34 | 265.72 | 64.63 | 875.22 |
| Last | 11.72 | 44.85 | 269.98 | 65.42 | 883.20 |
| Change | +0.12 | +0.15 | +0.60 | +0.15 | -7.48 |
| % Change | +1.03% | +0.34% | +0.22% | +0.23% | -0.84% |
| Volume | 16,900 | 21,281,900 | 2,436,900 | 12,382,400 | 505,600 |
| 20-Day Average Volume | 16,135 | 13,205,370 | 2,156,940 | 7,062,390 | 457,100 |
| Previous Close | 11.60 | 44.70 | 269.38 | 65.27 | 890.68 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 13.16 | 49.47 | 269.99 | 68.29 | 918.54 |
| 20-Day Raw Stochastic | 16.35% | 5.16% | 40.03% | 9.20% | 8.40% |
| 20-Day Relative Strength | 38.43% | 29.15% | 45.47% | 29.21% | 33.09% |
| Weighted Alpha | -40.23 | -34.43 | +9.45 | -23.49 | +9.82 |
| Today's Opinion | 88% Sell | 88% Sell | 72% Sell | 100% Sell | 8% Sell |
| Previous Opinion | 100% Sell | 88% Sell | 72% Sell | 100% Sell | 8% Buy |
| Last Month's Opinion | 24% Sell | 8% Buy | 40% Buy | 88% Sell | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.03% since 04/19/24 | -8.34% since 04/19/24 | +0.39% since 04/19/24 | -2.01% since 04/19/24 | -1.52% since 04/19/24 |
| Low | 11.15 on 04/23/24 | 44.34 on 04/26/24 | 265.72 on 04/26/24 | 64.63 on 04/26/24 | 875.22 on 04/26/24 |
| High | 12.93 on 04/23/24 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 915.70 on 04/24/24 |
| 1-Month | |||||
| %Chg | -22.07% since 03/26/24 | -14.65% since 03/26/24 | -4.18% since 03/26/24 | -9.65% since 03/26/24 | -8.34% since 03/26/24 |
| Low | 11.04 on 04/19/24 | 44.34 on 04/26/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 875.22 on 04/26/24 |
| High | 15.64 on 03/27/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 976.75 on 03/27/24 |
| 3-Month | |||||
| %Chg | -10.67% since 01/26/24 | -9.76% since 01/26/24 | -13.40% since 01/26/24 | -17.73% since 01/26/24 | -6.05% since 01/26/24 |
| Low | 11.04 on 04/19/24 | 44.34 on 04/26/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 875.22 on 04/26/24 |
| High | 22.32 on 03/18/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 80.00 on 01/29/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | -39.59% since 10/26/23 | -15.33% since 10/26/23 | +0.10% since 10/26/23 | -16.66% since 10/26/23 | +11.51% since 10/26/23 |
| Low | 10.89 on 12/13/23 | 44.34 on 04/26/24 | 249.70 on 10/31/23 | 64.63 on 04/26/24 | 769.19 on 10/27/23 |
| High | 23.20 on 11/07/23 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 14,346 | 90,596,128 | 144,488,960 | 81,266,176 | 97,762,816 |
| Shares Outstanding, K | 1,237 | 2,026,759 | 536,376 | 1,245,077 | 109,762 |
| Annual Sales | 42,810,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | -24,540,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 1,300,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 3,434,300,000 |
| Last Quarter Net Income | -4,580,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 1,159,600,000 |
| 60-Month Beta | 0.48 | 0.39 | 0.58 | 0.19 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.05 on 03/29/24 | -4.40 on 04/25/24 | 4.71 on 02/06/24 | -1.32 on 04/25/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 05/08/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.51 | 14.64 | 9.98 | 24.12 |